跳至主要内容
临床试验/CTRI/2023/10/058212
CTRI/2023/10/058212尚未招募2 期

In-vitro and Clinical evaluation of Duralabhadi kashaya ghanvati in comparison with Levofloxacin in the management of Mutrakrichha w.s.r to Urinary tract infection - NI

Parul Institute of ayurved0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Lakshana of Mutrakrichra which are similar to lower urinary tract infections like Burning (Sadahamutrata), Dysuria (Sarujamutrata), Frequency (Muhur-Muhurmutrata), urgency, strangury and Suprapubic tenderness.
  • 2. Patient suffering from fever.
  • 3. Laboratory investigations showing pus cells in urine more than 5 pus cells/HPF.
  • 4. Subjective parameter score total more than or equal to 6.

排除标准

  • 1. Patients not willing for trial.
  • 2. Patients suffering from medical illness like Poly-cystic kidneys, Hydronephrosis, Impaired renal functions, Malignancy of genito- urinary tract, Immuno-compromised patient, Uncontrolled Hypertension, Diabetes.
  • 3. Patients suffering from white discharge per vagina.
  • 4. Pregnant women suffering from UTI.

研究者

发起方
Parul Institute of ayurved

相似试验